Cart
sales@molnova.com
AG 99
CAS No. 122520-85-8
AG 99 ( (E)-Tyrphostin AG 99;(E)-Tyrphostin 46;Tyrphostin 46 )
Catalog No. M19940 CAS No. 122520-85-8
AG-99 is an inhibitor of EGFR kinase (IC50: 10 μM in the human epidermoid carcinoma cell line A431).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 27 | In Stock |
|
| 10MG | 42 | In Stock |
|
| 25MG | 66 | In Stock |
|
| 50MG | 87 | In Stock |
|
| 100MG | 147 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAG 99
-
NoteResearch use only not for human use.
-
Brief DescriptionAG-99 is an inhibitor of EGFR kinase (IC50: 10 μM in the human epidermoid carcinoma cell line A431).
-
DescriptionAG-99 is an inhibitor of EGFR kinase (IC50: 10 μM in the human epidermoid carcinoma cell line A431).
-
Synonyms(E)-Tyrphostin AG 99;(E)-Tyrphostin 46;Tyrphostin 46
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number122520-85-8
-
Formula Weight204.18
-
Molecular FormulaC10H8N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 20 mg/mL;Ethanol: 1 mg/mL;Water: Insoluble
-
SMILESNC(=O)C(=C\c1ccc(O)c(O)c1)\C#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gazit A et al. Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrophostins: potent inhibitors of EGF receptor tyrosine kinase in vitro. J Med Chem. 1996 Dec 6;39(25):4905-11.
molnova catalog
related products
-
5-Iodotubercidin
5-Iodotubercidin is a potent adenosine kinase inhibitor with IC50 of 26 nM. It inhibits nucleoside transporter, CK1, insulin receptor tyrosine kinase, phosphorylase kinase, PKA, CK2 and PKC.
-
Tarloxotinib bromide
Tarloxotinib bromide is an irreversible inhibitor of EGFR/HER2.
-
Afatinib
An irreversible, dual EGFR/HER2 inhibitor with IC50 of 0.5/0.4/10/14 nM for wt EGFR/EGFR L858R/EGFR L858R+T790M/HER2 respectively.
